Clinical Trials Logo

EBV Infections clinical trials

View clinical trials related to EBV Infections.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00078546 Completed - Clinical trials for Nasopharyngeal Cancer

EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)

CLANC
Start date: September 2003
Phase: Phase 1
Study type: Interventional

To determine the safety of the combination of CD45 monoclonal antibody (Mab) followed by intravenous injection of EBV specific CTL in patients with nasopharyngeal cancer. To compare the expansion, persistence and anti-tumor effects of the EBV specific CTL given after CD45 Mab administration with that observed in our first study. To obtain preliminary information on the safety and response to an extended dosage regimen of EBV-specific CTL in patients, who have stable disease or a partial response after the initial dose of EBV-specific CTL.